Synlogic Announces Presentation of Phenylketonuria Data at 14th International Congress of Inborn Errors of Metabolism Meeting
Late-Breaker Oral Presentation:
- Abstract #568: Reduction in Plasma Phenylalanine Levels in Patients with Phenylketonuria with Live Bacterial Therapeutic SYNB1618.
- Presenter: Dr.
Jerry Vockley, University of Pittsburghand UPMC Children's Hospital of Pittsburgh
Late Breaking News, Tuesday November 23rd, 10:45 AM– 11:45 AMLocal Time (AEDT) / 7:45 PM– 8:45 PM (EDT)
- Abstract #569: Enhanced potential for Phe lowering with SYNB1934, a live biotherapeutic with an improved PAL variant. Presenter: Dr.
Marja Puurunen, Synlogic
- Abstract #278: Development of an Optimized and Improved Phenylalanine Degrading Live Bacterial Therapeutic, SYNB1934, for the Treatment of Phenylketonuria. Presenter:
Catherine Monahan, Synlogic
- Abstract #474: Characterization of Dietary Protein Intake in PKU Patients. Presenter:
Dr. Mesaki K. Ndugga-Kabuye, Synlogic
In addition to the presentations on the PKU program, preclinical data for SYNB1353, an investigational methionine-consuming Synthetic Biotic medicine for the treatment of homocystinuria, will also be presented.
Learn more about Synlogic's programs and pipeline by visiting https://www.synlogictx.com/.
Synlogic™ is bringing the transformative potential of synthetic biology to medicine. With a premiere synthetic biology platform that leverages a reproducible, modular approach to microbial engineering,
This press release contains "forward-looking statements" that involve substantial risks and uncertainties for purposes of the safe harbor provided by the Private Securities Litigation Reform Act of 1995. All statements, other than statements of historical facts, included in this press release regarding strategy, future operations, clinical development plans, future financial position, future revenue, projected expenses, prospects, plans and objectives of management are forward-looking statements. In addition, when or if used in this press release, the words "may," "could," "should," "anticipate," "believe," "estimate," "expect," "intend," "plan," "predict" and similar expressions and their variants, as they relate to
View original content:https://www.prnewswire.com/news-releases/synlogic-announces-presentation-of-phenylketonuria-data-at-14th-international-congress-of-inborn-errors-of-metabolism-meeting-301420438.html
Media Contact: Bill Berry, Berry & Company Public Relations, Phone: 212-253-8881, Email: email@example.com or Investor Contact: Daniel Rosan, Synlogic, Inc., Phone: 617-401-9152, Email: firstname.lastname@example.org